Stock Market

Stocks are stagnating lower on Thursday, but aren’t declining with any real staying power. As boring as that action can be, investors need to be careful not to overtrade. If need be, walk away from your desk for a while and get some fresh air. Then come back and let’s talk about some top stock trades.

Top Stock Trades for Tomorrow #1: Rite Aid

Shares of Rite Aid (NYSE:RAD) are making new lows (what else is new) as the company reported fourth-quarter earnings. RAD missed on earnings and revenue estimates, provided weak guidance and announced 1:20 reverse split.

Let’s put it this way: A healthy company doesn’t reverse split.

We’ve said to avoid RAD stock over and over throughout the years. The company is circling the drain and there’s no reason to trade this one when there’s so many other options out there. Even shorts can be burned by a temporary squeeze.

Top Stock Trades for Tomorrow #2: CVS Health

top stock trades for CVS

A cheap valuation, decent growth and a solid dividend aren’t enough to support CVS Health (NYSE:CVS). I highlighted this one as a trade last month before shares promptly jumped about 10%. Since then though, the stock has come back down to this $52 level twice now.

If it gets there again, will it hold as support? The chart looks grim and while I was a buyer on the initial test of $52, I’m not now. There’s no telling where this will find support if the recent lows give way.

On the upside, CVS needs to get above downtrend resistance and the 20-day moving average.

Top Stock Trades for Tomorrow #3: UnitedHealth

top stock trades for UNH

UnitedHealth (NYSE:UNH) has a similar chart, with downtrend resistance squeezing the share price into repeated support. Uptrend support (purple line) has given way, so it’s all up to bulls to step up to the plate between Thursday’s lows and $235.

A drop below $230 puts UNH in no man’s land for the time being. If it holds, see if UNH can get above $246 to $250 on a rally.

Top Stock Trades for Tomorrow #4: Canopy Growth

top stock trades for CGC

Remember when we talked about the very slow consolidation in Canopy Growth (NYSE:CGC) stock a few months ago? We ended up stopping out of this one as uptrend support and the 50-day moving average gave way.

It looked like $42 was going to hold up as support, but it wasn’t worth the risk to us. As you can see in April though, $42 actually turned into resistance after acting as temporary support.

CGC may pull in some buyers near the 200-day, but cannabis stocks like CGC, Cronos Group (NASDAQ:CRON), Tilray (NASDAQ:TLRY) and others are under pressure. It’s not clear yet whether the 200-day will act as support.

If it does, bulls have a clear line in the sand. If not, look for potential short-term support in the $37 to $38 area. Below that and ~$34 is in the cards.

Top Stock Trades for Tomorrow #5: Intercept Pharmaceuticals

top stock trades for ICPT

Disappointing late-stage data disappointed investors in Intercept Pharmaceuticals (NASDAQ:ICPT), which is down almost 13% on the day as a result.

Prior resistance near $115 did not act as support, as ICPT is knifing through all three major moving averages on Thursday. It’s not a good look for bulls. If ICPT can’t get back above the 200-day and 50-day moving averages, or if it does temporarily but they turn into resistance, then the stock could be heading lower.

If that’s the case, a test of uptrend support is certainly possible, currently about $15 or 14.3% below current levels. If shares bounce from current levels, look for a retest of $115 and see how ICPT does then.

Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities.

Articles You May Like

Watch for a Bubble as Beyond Meat Stock Begins to Cool
Stocks making the biggest moves after hours: Adobe, US Steel, and more
The One Metric That Makes Nio Stock a Loser
7 S&P 500 Stocks to Buy With Little Debt and Lots of Profits
Federal Reserve’s quick pivot to easier policy started with a Trump tweet on trade

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.